Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Clinical Investigation
|
December 1, 1993
Reduced beta 1 receptor messenger RNA abundance in the failing human heart
M R Bristow, W A Minobe, M V Raynolds, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy
F L Anderson, J D Port, B B Reid, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Receptor pharmacology of carvedilol in the human heart
M R Bristow, P Larrabee, W Minobe, et al.
The Clinical Investigator
|
January 1, 1992
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes
M R Bristow, P Larrabee, B Müller-Beckmann, et al.
The Journal of Trauma
|
October 1, 1983
The effect of ketanserin, a specific serotonin antagonist, on burn shock hemodynamic parameters in a porcine burn model
C J Holliman, T R Meuleman, K R Larsen, et al.
Circulation
|
March 1, 1990
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart
J D Port, E M Gilbert, P Larrabee, et al.
Circulation
|
August 1, 1990
Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium
M R Bristow, R E Hershberger, J D Port, et al.
Circulation
|
September 1, 1994
Age-related changes in beta-adrenergic neuroeffector systems in the human heart
M White, R Roden, W Minobe, et al.
Statistics in Medicine
|
May 19, 2018
Clustering and variable selection in the presence of mixed variable types and missing data
C B Storlie, S M Myers, S K Katusic, et al.
European Heart Journal
|
April 1, 1996
Cardiac adrenergic receptor effects of carvedilol
T Yoshikawa, J D Port, K Asano, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Clinical Investigation
|
December 1, 1993
Reduced beta 1 receptor messenger RNA abundance in the failing human heart
M R Bristow, W A Minobe, M V Raynolds, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy
F L Anderson, J D Port, B B Reid, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1992
Receptor pharmacology of carvedilol in the human heart
M R Bristow, P Larrabee, W Minobe, et al.
The Clinical Investigator
|
January 1, 1992
Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes
M R Bristow, P Larrabee, B Müller-Beckmann, et al.
The Journal of Trauma
|
October 1, 1983
The effect of ketanserin, a specific serotonin antagonist, on burn shock hemodynamic parameters in a porcine burn model
C J Holliman, T R Meuleman, K R Larsen, et al.
Circulation
|
March 1, 1990
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart
J D Port, E M Gilbert, P Larrabee, et al.
Circulation
|
August 1, 1990
Beta-adrenergic pathways in nonfailing and failing human ventricular myocardium
M R Bristow, R E Hershberger, J D Port, et al.
Circulation
|
September 1, 1994
Age-related changes in beta-adrenergic neuroeffector systems in the human heart
M White, R Roden, W Minobe, et al.
Statistics in Medicine
|
May 19, 2018
Clustering and variable selection in the presence of mixed variable types and missing data
C B Storlie, S M Myers, S K Katusic, et al.
European Heart Journal
|
April 1, 1996
Cardiac adrenergic receptor effects of carvedilol
T Yoshikawa, J D Port, K Asano, et al.
Page
of 6